Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Alnylam Pharmaceuticals Inc.
Director
BeOne Medicines Ltd.
Director
Vaxcyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202699.4%
-
Alnylam Pharmaceuticals Inc. May 16, 202494.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Vaxcyte Inc. | Grant or award | +2,194 | — | — |
| Jun 11, 2026 | BeOne Medicines Ltd. | Grant or award | +18,980 | — | — |
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| Jan 15, 2026 | Vaxcyte Inc. | Grant or award | +1,357 | — | — |
| Jun 12, 2025 | Vaxcyte Inc. | Grant or award | +1,148 | — | — |
| May 21, 2025 | BeOne Medicines Ltd. | Grant or award | +10,985 | — | — |
| May 8, 2025 | Alnylam Pharmaceuticals Inc. | Grant or award | +775 | — | — |
| Jun 5, 2024 | BeOne Medicines Ltd. | Grant or award | +16,341 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.